Related Experiment Video
Updated: Feb 15, 2026

Chronic Stress Shifts Effort-Related Choice Behavior in a Y-Maze Barrier Task in Mice
Published on: August 13, 2020
Chronic total occlusion: Does anti-platelet choice impact outcomes?
Wassim Shatila1,2,3, Zvonimir Krajcer1,2,3
1Department of Cardiology, Texas Heart Institute, Houston, Texas.
Insights
Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) leads to worse outcomes. The TIGER-BVS trial investigates if ticagrelor improves vasomotor activity and outcomes after CTO PCI compared to clopidogrel.
Area of Science:
- Cardiology
- Interventional Cardiology
- Pharmacology
Background:
- Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is linked to poorer patient results.
- CTO may contribute to vasomotor dysfunction, impacting coronary blood flow.
- Ticagrelor, a P2Y12 inhibitor, has shown potential to increase local adenosine levels.
Discussion:
- The TIGER-BVS trial aims to compare ticagrelor and clopidogrel in CTO PCI.
- The study will evaluate the effects on vasomotor activity, a key factor in coronary blood flow.
- Outcomes following successful CTO PCI will be assessed in both treatment arms.
Key Insights:
- Ticagrelor's potential to modulate vasomotor function after CTO PCI warrants investigation.
- Understanding the impact of P2Y12 inhibitors on adenosine may reveal new therapeutic avenues.
- Comparing ticagrelor with clopidogrel provides direct clinical insight into optimizing CTO PCI management.
Outlook:
- This research could establish ticagrelor as a preferred agent for CTO PCI.
- Findings may influence future guidelines for antiplatelet therapy in complex coronary interventions.
- Further studies could explore the long-term cardiovascular benefits of ticagrelor in CTO patients.
Abstract:
Chronic total occlusion (CTO) is associated with worse outcomes compared to non CTO percutaneous coronary intervention (PCI). CTO might be associated with vasomotor dysfunction Ticagrelor is a novel P2Y12 inhibitor that increases local adenosine The TIGER-BVS trial plans to assess the impact of using ticagrelor vs. clopidogrel on vasomotor activity and outcomes after successful CTO PCI.
More Related Videos
Related Concept Videos
Mate Choice
Predicting Reaction Outcomes
Impact of Groups on Groups
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Impact
When particles with different initial velocities collide, they induce deformation by applying equal and opposite impulses. At the point of maximum deformation, the particles move together with...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...

